Specialty

Interventions in Health Offerings and Allergenic Food Management in Restaurants

Interventions in health offerings and allergenic food management that shifted towards  Mediterranean dietary patterns were found to be effective for improving the quality of restaurant menus. In recent decades, there has been a rise in the consumption of restaurant meals, due to work, study, and leisure commitments. Restaurants can be potential targets for interventions in...

Bipolar Androgen Therapy With Nivolumab for Metastatic Castration-Resistant Prostate Cancer

Results of a phase 2 study indicate that bipolar androgen therapy with nivolumab may augment the anti-tumor immunologic response of the body against metastatic castration-resistant prostate cancer, which is further strengthened by immune checkpoint inhibition. Bipolar androgen therapy (BAT) in metastatic castration-resistant prostate cancer (mCRPC) patients drives testosterone levels above the physiologic range and then...

Prognostic Significance of Surgery and Radiotherapy in Localized Prostate Cancer

A randomized controlled trial found that nomograms based on multiple Cox regression models could effectively predict the risk factors associated with overall survival and cancer-specific survival in patients with localized prostate cancer as well as assess survival differences between surgery and radiotherapy.  Prostate cancer affects a substantial proportion of men across the globe, with more...

Health Coaching Program for Metabolic Syndrome in Prostate Cancer Patients

A nurse-led mobile-based health coaching program promoted positive lifestyle changes that improved various parameters of metabolic syndrome in prostate cancer patients. Prostate cancer patients are prone to adverse metabolic changes that stem from the physical effects of androgen deprivation therapy (ADT). These changes include body fat accumulation and abnormal fasting glucose levels, with subsequent development...

Deep Learning Algorithm-Based Prediction of Bone Metastases in Prostate Cancer

A retrospective cohort study finds that multimodal radiomics and pathomics based on deep learning algorithms are useful tools for predicting the risk of bone metastases in patients diagnosed with primary prostate cancer. Bone metastasis is a common consequence of disease progression in primary prostate cancer patients and plays an important role in the morbidity and...

Prostate-Specific Antigen and Magnetic Resonance Imaging for Prostate Cancer Screening

Secondary analysis of a prospective trial finds that while repeated screening for prostate cancer is crucial to the detection of pathology, the proportion of magnetic resonance imaging scans that prompt suspicion of cancer is relatively low. Prostate cancer screening with prostate-specific antigen (PSA) plays a pivotal role in decreasing cancer-related mortality. Screening with PSA testing...

AZD4635 With Durvalumab or Oleclumab for Metastatic Castration-Resistant Prostate Cancer

A newly published phase 2 study finds that the antitumor effect of AZD4635 with durvalumab or oleclumab is minimal in pretreated metastatic castration-resistant prostate cancer, with the treatment regimen being well-tolerated and generally safe. Metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis and limited overall survival rates. The standard treatment for mCRPC patients comprises...

Multiple Sclerosis Treatment Complications: IFNβ-Linked Thrombotic Microangiopathy

Multiple sclerosis treatment with interferon beta may infrequently cause thrombotic microangiopathy, resulting in acute kidney injury. However, a newly published literature review finds that early identification of the complication and treatment with eculizumab may help prevent end-stage renal disease. Multiple sclerosis (MS) is a prevalent inflammatory demyelinating disorder of the central nervous system, mostly affecting...

Identifying Biomarkers for Multiple Sclerosis Disease Activity and Progress

A cohort study found glial fibrillary acid protein may be a reliable cerebrospinal fluid biomarker for differentiating progressive multiple sclerosis from relapsing disease. Multiple sclerosis (MS) presents a complex challenge in clinical management due to its varied progression patterns and the absence of precise biological markers to predict disease course. Two MS types, relapsing and...
<< >>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.